IRON

75.1401.27%
WJ

William Jacob Savage

Chief Medical Officer

Dr. William Jacob Savage, also known as Will, MD., Ph.D., is Chief Medical Officer of Disc Medicine, Inc. since August 2021. He served as Vice President and Head of Clinical Development at Disc Medicine, Inc. from August 2020 to August 2021. He has experience of hematology and transfusion medicine clinical research, having worked across academic institutions, biopharma and biotech. Prior to joining Disc Medicine, Inc. He served as Senior Medical Director at Magenta Therapeutics from July 2019 to July 2020, where he managed clinical development activities from preclinical through phase 2. Prior to Magenta Therapeutics, he was the Global Clinical Development Lead in Hematology at Shire plc and Takeda Pharmaceutical Company, following its acquisition of Shire, both pharmaceutical companies, from January 2017 to July 2019. Before transitioning to biotech/biopharma, he was an Assistant Professor of Pathology at Harvard Medical School/Brigham and Women's Hospital from July 2012 to January 2017. He started his career at Johns Hopkins University School of Medicine, where he trained in pediatric hematology/oncology and transfusion medicine. He was Associate Medical Director, Transfusion Medicine and Assistant Professor of Pediatric Hematology at Johns Hopkins University School of Medicine. He received his BA in Biochemistry magna cum laude from Columbia University, his MD with honors in research from Weill Cornell Medical College and his PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health.

公司職務